Combined medwatch submitted to the fda on 07/dec/2023.Clinical study: 01 - 040.A review of the device labeling notes the following: the current x-tack¿ endoscopic helix tacking system instructions for use (ifu) addressed the known and potential events of "pain (esophageal)" as follows: the apollo endosurgery overstitch¿ endoscopic suture system (ess) is intended for endoscopic suture cinch-deployment difficulty.Possible complications that may result from using the endoscopic suturing system include, but may not be limited to: · pharyngitis / sore throat.· nausea and / or vomiting.· abdominal pain and / or bloating.· hemorrhage.· hematoma.· conversion to laparoscopic or open procedure.· stricture.· infection / sepsis.· pharyngeal, colonic and/or esophageal perforation.· esophageal, colonic and/or pharyngeal laceration.· intra-abdominal (hollow or solid) visceral injury.· aspiration.· wound dehiscence.· acute inflammatory tissue reaction.· death.Note: any serious incident that has occurred in relation to the device should be reported to apollo endosurgery and any appropriate government entity.Additional information: the investigator determined that a device history record (dhr) review is required for this complaint due to the complaint being reportable.There are no other complaints against this lot number, af04744, and allegation.The subject product met all specifications and requirements in effect at the time of manufacture.Device evaluation summary: assessment of the device involved in this complaint was not possible, and it has not been possible to determine the root cause for this event.
|